Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor‐Naïve Patients With Myelofibrosis From the Multicenter, Open‐Label, Phase 2 Study (REFINE)

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Francesco Passamonti, James M. Foran, Anand Tandra, Valerio De Stefano, Maria Laura Fox, Ahmad Mattour, Mary Frances McMullin, Andrew C. Perkins, Gabriela Rodriguez‐Macías, Hassan A. Sibai, Akshanth R. Polepally, Yan Sun, Avijeet S. Chopra, Jason G. Harb, Qin Qin, Jalaja Potluri, Jonathan How
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet